Cumberland Partners’s ResMed RMD Stock Holding History

Cumberland Partners’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.85M	Hold	9,500	–	–	0.12%	99
2026 Q1	$2.13M	Sell	9,500 -11,500	-55%	-$2.87M	0.16%	89
2025 Q4	$5.06M	Buy	21,000 +8,000	+62%	+$2.05M	0.31%	63
2025 Q3	$3.56M	Hold	13,000	–	–	0.23%	76
2025 Q2	$3.35M	Sell	13,000 -1,000	-7%	-$239K	0.23%	75
2025 Q1	$3.13M	Buy	14,000 +1,000	+8%	+$233K	0.24%	70
2024 Q4	$2.97M	Buy	13,000 +11,000	+550%	+$2.65M	0.21%	75
2024 Q3	$488K	Buy	+2,000	New	+$447K	0.03%	155

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Cumberland Partners's RMD Position: Q2 2026 in Review

Cumberland Partners held its ResMed (RMD) position steady in Q2 2026 at 9,500 shares worth $1.85M. The position accounts for 0.12% of the portfolio, ranked #99.

Cumberland Partners first reported a position in RMD in Q3 2024 and has held it in 8 quarters since. The position peaked at $5.06M in Q4 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Cumberland Partners held 9,500 shares of ResMed worth $1.85M as of Q2 2026.
Cumberland Partners left its ResMed share count unchanged in Q2 2026.
ResMed made up 0.12% of Cumberland Partners's portfolio in Q2 2026, its #99 holding.
Cumberland Partners first reported a position in ResMed in Q3 2024 and has held it in 8 quarters since.
Cumberland Partners's ResMed position peaked at $5.06M in Q4 2025.
882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Cumberland Partners's 13F filing for Q2 2026, filed 6 Aug 2026.